Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
PLoS One. 2011;6(7):e19753. doi: 10.1371/journal.pone.0019753. Epub 2011 Jul 5.
Early diagnosis and prompt, effective treatment of uncomplicated malaria is critical to prevent severe disease, death and malaria transmission. We assessed the impact of rapid malaria diagnostic tests (RDTs) by community health workers (CHWs) on provision of artemisinin-based combination therapy (ACT) and health outcome in fever patients.
METHODOLOGY/PRINCIPAL FINDINGS: Twenty-two CHWs from five villages in Kibaha District, a high-malaria transmission area in Coast Region, Tanzania, were trained to manage uncomplicated malaria using RDT aided diagnosis or clinical diagnosis (CD) only. Each CHW was randomly assigned to use either RDT or CD the first week and thereafter alternating weekly. Primary outcome was provision of ACT and main secondary outcomes were referral rates and health status by days 3 and 7. The CHWs enrolled 2930 fever patients during five months of whom 1988 (67.8%) presented within 24 hours of fever onset. ACT was provided to 775 of 1457 (53.2%) patients during RDT weeks and to 1422 of 1473 (96.5%) patients during CD weeks (Odds Ratio (OR) 0.039, 95% CI 0.029-0.053). The CHWs adhered to the RDT results in 1411 of 1457 (96.8%, 95% CI 95.8-97.6) patients. More patients were referred on inclusion day during RDT weeks (10.0%) compared to CD weeks (1.6%). Referral during days 1-7 and perceived non-recovery on days 3 and 7 were also more common after RDT aided diagnosis. However, no fatal or severe malaria occurred among 682 patients in the RDT group who were not treated with ACT, supporting the safety of withholding ACT to RDT negative patients.
CONCLUSIONS/SIGNIFICANCE: RDTs in the hands of CHWs may safely improve early and well-targeted ACT treatment in malaria patients at community level in Africa.
ClinicalTrials.gov NCT00301015.
早期诊断和及时、有效的治疗无并发症疟疾对于预防重症疾病、死亡和疟疾传播至关重要。我们评估了社区卫生工作者(CHWs)使用快速疟疾诊断检测(RDT)对提供基于青蒿素的联合疗法(ACT)和发热患者健康结果的影响。
方法/主要发现:在坦桑尼亚滨海地区基巴哈区,五个疟疾高发村庄的 22 名 CHWs 接受了使用 RDT 辅助诊断或仅临床诊断(CD)治疗无并发症疟疾的培训。每位 CHW 被随机分配在第一周使用 RDT 或 CD,此后每周交替使用。主要结局是提供 ACT,主要次要结局是在第 3 天和第 7 天的转诊率和健康状况。CHWs 在五个月内招募了 2930 名发热患者,其中 1988 名(67.8%)在发热发作后 24 小时内就诊。在 RDT 周期间,1457 名患者中有 775 名(53.2%)接受了 ACT,在 CD 周期间,1473 名患者中有 1422 名(96.5%)接受了 ACT(比值比(OR)0.039,95%CI 0.029-0.053)。CHWs 在 1457 名患者中的 1411 名(96.8%,95%CI 95.8-97.6)中遵守了 RDT 结果。在 RDT 周期间,纳入当天转诊的患者更多(10.0%),而在 CD 周期间(1.6%)则更少。在 RDT 辅助诊断后,第 1-7 天的转诊率和第 3 天和第 7 天的感知未康复率也更高。然而,在未接受 ACT 治疗的 682 名 RDT 阴性患者中,没有发生致命或严重疟疾,这支持了对 RDT 阴性患者不使用 ACT 的安全性。
结论/意义:在非洲社区一级,CHWs 使用 RDT 可以安全地提高疟疾患者的早期和针对性 ACT 治疗。
ClinicalTrials.gov NCT00301015。